Browsing: Zepbound
Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month—well below the $2,000 list…
Injectable glucagon-like peptide-1 agonists, or GLP-1s, were first approved as diabetes medications 20 years ago. They’ve since become popular as…
California recently passed a budget for 2025-2026 that eliminates Medicaid coverage for GLP-1 agonists for weight loss. Other states are…
A commercial airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the…
Officials in the U.K. have warned that increasingly popular weight-loss drugs like Ozempic may carry extra risks for people who…
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health…
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss medicine tirzepatide. Susan McGowan, 58, died from…
Topline Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost…
At least two in five U.S. adults — or more than 57 million people – under the age of 65…
Enabling patients to order prescription medications directly from the drug maker is an emerging trend exemplified by the launch this…